SYNTHESIS AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP ANALYSIS OF 2-(ARYL OR HETEROARYL)QUINOLIN-4-AMINES, A NEW CLASS OF ANTI-HIV-1 AGENTS

被引:171
作者
STREKOWSKI, L
MOKROSZ, JL
HONKAN, VA
CZARNY, A
CEGLA, MT
WYDRA, RL
PATTERSON, SE
SCHINAZI, RF
机构
[1] VET AFFAIRS MED CTR,ATLANTA,GA 30033
[2] INST PHARMACOL,PL-31343 KRAKOW,POLAND
[3] EMORY UNIV,SCH MED,DEPT PEDIAT,BIOCHEM PHARMACOL LAB,ATLANTA,GA 30033
关键词
D O I
10.1021/jm00109a031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thirty-eight 2-(aryl or heteroaryl)quinolin-4-amines, N,N-disubstituted, N-monosubstituted, and without a substituent at the amino group have been synthesized with use of novel chemistries developed by us recently. Some of these derivatives show anti-HIV-1 activity at a concentration level of 1-mu-M and low cell toxicity in vitro. The most active and least toxic compounds are derivatives of 2-(3-pyridyl)quinoline. The results of the quantitative structure-activity relationship analyses, including several classical, linear regression correlations and a Free-Wilson approach, of de novo model, provide guidelines for the design of new active compounds of this class.
引用
收藏
页码:1739 / 1746
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 1976, MOL CONNECTIVITY CHE
[2]  
Chou J., 1985, COMPUTER SOFTWARE AP
[3]  
COBURN RA, 1987, QSAR PC PAR QUANTITA
[4]   MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES [J].
FREE, SM ;
WILSON, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1964, 7 (04) :395-&
[5]   GENETIC-VARIATION IN HTLV-III/LAV OVER TIME IN PATIENTS WITH AIDS OR AT RISK FOR AIDS [J].
HAHN, BH ;
SHAW, GM ;
TAYLOR, ME ;
REDFIELD, RR ;
MARKHAM, PD ;
SALAHUDDIN, SZ ;
WONGSTAAL, F ;
GALLO, RC ;
PARKS, ES ;
PARKS, WP .
SCIENCE, 1986, 232 (4757) :1548-1553
[6]  
HALL LH, 1989, MOLCONN 2 VERSION 2
[7]  
Kaliszan R., 1987, QUANTITATIVE STRUCTU
[8]   DERIVATION AND SIGNIFICANCE OF VALENCE MOLECULAR CONNECTIVITY [J].
KIER, LB ;
HALL, LH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) :583-589
[9]   QUANTITATION OF SOLVENT POLARITY BASED ON MOLECULAR-STRUCTURE [J].
KIER, LB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (08) :930-933
[10]  
KIER LB, 1986, MOL CONNECTIVITY CHE